@CNN: The FDA announced had not identified any “new or unexpected safety findings” related to Nuplazid, a drug used to treat psychosis in Parkinson’s patients, though it did find potentially troubling prescribing practices https://t.co/vOiKg7jV5R

The FDA announced had not identified any "new or unexpected safety findings" related to Nuplazid, a drug used to treat psychosis in Parkinson's patients, though it did find potentially troubling prescribing practices https://t.co/vOiKg7jV5R

— CNN (@CNN) September 21, 2018